Checkpoint Inhibitors in Multiple Myeloma: Intriguing Potential and Unfulfilled Promises
MagnetisMM-5 I Multiple Myeloma Clinical Trials
Mean scores over time for EORTC QLQ-C30 domains with ixa-dex vs... | Download Scientific Diagram
APOLLO trial results: Addition of daratumumab to pomalidomide + dexamethasone in relapsed/refractory multiple myeloma
New Agents in Multiple Myeloma 2015 and Beyond | PPT
Indications & Dosing | DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) HCP
Multiple Myeloma Clinical Trials
EMN2023: April 20-22, 2023 32 | 2023; 7:S2 P38 PATIENT-REPORTED OUTCOMES (PRO) IN RELAPSED/ REFRACTORY MULTIPLE MYELOMA (RRMM) T
DARA + pom-dex for R/R multiple myeloma | VJHemOnc
Pomalidomide and Dexamethasone (Pom-Dex) With or Without Daratumumab (DARA) in Patients (Pts) With Relapsed or Refractory Multi
For Multiple Myeloma
Cancers | Free Full-Text | Checkpoint Inhibitors in Multiple Myeloma: Intriguing Potential and Unfulfilled Promises
Debate on Efficacy and Patient Selection With Ixa-Pom-Dex in Relapsed/Refractory MM
Part 1 Results of Belantamab Mafodotin in Combination with Pomalidomide and Dexamethasone for RRMM
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial - The Lancet Oncology
Indications & Dosing | DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) HCP
Medicina | Free Full-Text | Real-Life Experience with Pomalidomide plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma: A Retrospective and Prospective Study
Kaplan–Meier analysis of TTP and OS with ixa-dex vs pom-dex in the ITT... | Download Scientific Diagram
PFS with ixa-dex vs pom-dex in the ITT population A Kaplan–Meier... | Download Scientific Diagram
New myeloma drugs improve response and extend survival | MDedge Hematology and Oncology
Daratumumab Alone or in Combination with Lenalidomide/Dexamethasone or Pomalidomide/Dexamethasone for Relapsed/Refractory MM | Research To Practice
